Freespaz

Mebeverine 200 mg

• Therapeutic Class Antispasmodic
• Dosage Form F.C. Tablets

Each F.C. tablet contains Mebeverine Hydrochloride 135 mg.

Indications:

• For the symptomatic treatment of irritable bowel syndrome and other conditions usually included in this grouping, such as: chronic irritable colon, spastic constipation, mucous colitis, spastic colitis.
• It is effectively used to treat the symptoms of these conditions, such as: colicky abdominal pain and cramps, persistent, non-specific diarrhea (with or without alternating constipation) and flatulence.

Posology and method of administration:

Duration of use is not limited.

If one or more doses are missed, the patient should continue with the next dose as prescribed; the missed dose(s) should not be taken in addition to the regular dose.

• The tablets should be swallowed with a sufficient amount of water (at least 100 ml water). They should not be chewed because of the unpleasant taste.
• Adults (including the elderly): One tablet of 135 mg three times a day, preferably 20 minutes before meals. After a period of several weeks, when the desired effect has been obtained, the dosage may be gradually reduced.
• Pediatric Population: Mebeverine tablets are not recommended for use in children and adolescents below 18, due to insufficient data on safety and efficacy.

Special Population: No posology studies in elderly, renal and/or hepatic impaired patients have been performed. No specific risk for elderly, renal and/or hepatic impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in elderly, renal and/or hepatic impaired patients.

Packaging:
Carton box contains 2 strips each strip contains 10 Film Coated tablets.